The Pennant Group (NASDAQ:PNTG – Get Free Report)‘s stock had its “overweight” rating reiterated by research analysts at Stephens in a research note issued on Wednesday,Benzinga reports. They presently have a $38.00 price objective on the stock. Stephens’ price target would suggest a potential upside of 51.45% from the company’s previous close.
A number of other equities research analysts have also issued reports on the company. Truist Financial decreased their price target on The Pennant Group from $32.00 to $28.00 and set a “hold” rating for the company in a research note on Friday, March 7th. Wells Fargo & Company started coverage on The Pennant Group in a research report on Thursday, December 19th. They set an “equal weight” rating and a $33.00 target price for the company. Two equities research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $34.80.
Get Our Latest Research Report on The Pennant Group
The Pennant Group Trading Down 1.3 %
Institutional Investors Weigh In On The Pennant Group
A number of institutional investors and hedge funds have recently bought and sold shares of PNTG. Intech Investment Management LLC purchased a new position in shares of The Pennant Group during the third quarter valued at $232,000. Charles Schwab Investment Management Inc. grew its holdings in The Pennant Group by 1.2% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 242,743 shares of the company’s stock worth $8,666,000 after acquiring an additional 2,982 shares in the last quarter. FMR LLC increased its position in The Pennant Group by 51.3% during the 3rd quarter. FMR LLC now owns 2,528,512 shares of the company’s stock valued at $90,268,000 after purchasing an additional 856,838 shares during the period. D.A. Davidson & CO. raised its holdings in shares of The Pennant Group by 4.0% in the 3rd quarter. D.A. Davidson & CO. now owns 15,126 shares of the company’s stock valued at $540,000 after purchasing an additional 575 shares in the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank lifted its position in shares of The Pennant Group by 11.4% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 24,214 shares of the company’s stock worth $864,000 after purchasing an additional 2,476 shares during the period. 85.88% of the stock is owned by institutional investors.
About The Pennant Group
The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.
Featured Stories
- Five stocks we like better than The Pennant Group
- Top Stocks Investing in 5G Technology
- Homebuilders in Freefall: Bargain Opportunity or Falling Knife?
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- The 3 Most Talked About Investments on WallStreetBets Right Now
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- Analyst Targets Signal More Growth in CrowdStrike Stock
Receive News & Ratings for The Pennant Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Pennant Group and related companies with MarketBeat.com's FREE daily email newsletter.